DFN-11 Injection in Episodic Migraine With or Without Aura
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 25 Jul 2017
At a glance
- Drugs DFN 11 (Primary)
- Indications Migraine with aura; Migraine without aura
- Focus Therapeutic Use
- Acronyms RESTOR
- Sponsors Dr Reddys Laboratories
- 13 Mar 2017 Status changed from recruiting to active, no longer recruiting.
- 02 Mar 2017 Planned End Date changed from 1 Mar 2017 to 1 Nov 2017.
- 02 Mar 2017 Planned primary completion date changed from 1 Feb 2017 to 1 Jun 2017.